Hyaluronic Acid (Supartz®)A Review of its Use in Osteoarthritis of the Knee

被引:0
作者
Monique P. Curran
机构
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源
Drugs & Aging | 2010年 / 27卷
关键词
Osteoarthritis; Hyaluronic Acid; Synovial Fluid; Simple Analgesic; Swedish Trial;
D O I
暂无
中图分类号
学科分类号
摘要
Hyaluronic acid (Supartz®; molecular weight 620–1170 kDa) is a sterile, viscoelastic, non-pyogenic solution that is indicated as a medical device for the treatment of pain in patients with osteoarthritis of the knee who have failed to respond adequately to conservative nonpharmacological therapy and simple analgesics.
引用
收藏
页码:925 / 941
页数:16
相关论文
共 271 条
  • [1] Migliore A(2008)Intra-articular use of hyaluronic acid in the treatment of osteoarthritis Clin Interv Aging 3 365-9
  • [2] Granata M(2002)Hyaluronan and homeostasis: a balancing act J Biol Chem 277 4581-4
  • [3] Tammi MI(2008)Simple primary structure, complex turnover regulation and multiple roles of hyaluronan J Biochem 144 131-7
  • [4] Day AJ(2000)Intra-articular hyaluronan therapy Curr Opin Rheumatol 12 468-74
  • [5] Turley EA(1997)Hyaluronan: its nature, distribution, functions and turnover J Intern Med 242 27-33
  • [6] Itano N(1985)Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies Ann Rheum Dis 44 817-22
  • [7] Marshall KW(1967)Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids Arthritis Rheum 10 357-76
  • [8] Fraser JR(1993)Viscosupplementation: a new concept in the treatment of osteoarthritis J Rheumatol Suppl 39 3-9
  • [9] Laurent TC(1991)Oxidative damage to synovial fluid from the inflamed rheumatoid joint detected by 1H NMR spectroscopy J Pharm Biomed Anal 9 75-82
  • [10] Laurent UB(2000)Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update Arthritis Rheum 43 1905-15